Abstract
Mendelian randomization (MR) is a causal inference method that uses genetic variants as instrumental variables (IVs) to estimate the causal effect of a modifiable exposure on the outcome of interest, even in the presence of unmeasured confounding. However, the core assumptions defining a valid IV might be violated in practice due to the presence of population stratification and/or widespread horizontal pleiotropy, leading to biased inference and possibly misleading scientific conclusions. To address this pressing challenge, we propose a novel MR method that first Selects valid genetic instruments and then performs Post-selection Inference (MR-SPI) to construct robust confidence intervals based on two-sample genome-wide summary statistics. Specifically, our proposed MR-SPI method has four steps: (1) selecting relevant IVs that are associated with the exposure variable using hard thresholding; (2) the selected relevant IVs vote for each other to be a valid IV if their ratio estimates of the causal effect are similar; (3) selecting valid IVs by majority/plurality voting or finding the maximum clique of the voting matrix; and (4) constructing robust confidence intervals using the searching and sampling technique. We conduct extensive simulations to assess the practical performance of our method. Finally, we apply our MR-SPI method to learn causal relationships among 146 exposure-outcome pairs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used openly available human data that were originally located at: https://gwas.mrcieu.ac.uk/ http://www.cardiogramplusc4d.org/data-downloads/ https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files https://www.covid19hg.org/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
